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ABSTRACT Previous work has shown that environmental and clinical isolates of Aspergillus fumigatus represent a diverse popu-

lation that occupies a variety of niches, has extensive genetic diversity, and exhibits virulence heterogeneity in a number of animal models of invasive pulmonary aspergillosis (IPA). However, mechanisms explaining differences in virulence among A. fumigatus isolates remain enigmatic. Here, we report a significant difference in virulence of two common lab strains, CEA10 and
AF293, in the murine triamcinolone immunosuppression model of IPA, in which we previously identified severe low oxygen microenvironments surrounding fungal lesions. Therefore, we hypothesize that the ability to thrive within these lesions of low oxygen promotes virulence of A. fumigatus in this model. To test this hypothesis, we performed in vitro fitness and in vivo virulence
analyses in the triamcinolone murine model of IPA with 14 environmental and clinical isolates of A. fumigatus. Among these
isolates, we observed a strong correlation between fitness in low oxygen in vitro and virulence. In further support of our hypothesis, experimental evolution of AF293, a strain that exhibits reduced fitness in low oxygen and reduced virulence in the triamcinolone model of IPA, results in a strain (EVOL20) that has increased hypoxia fitness and a corresponding increase in virulence.
Thus, the ability to thrive in low oxygen correlates with virulence of A. fumigatus isolates in the context of steroid-mediated murine immunosuppression.
IMPORTANCE Aspergillus fumigatus occupies multiple environmental niches, likely contributing to the genotypic and phenotypic heterogeneity among isolates. Despite reports of virulence heterogeneity, pathogenesis studies often utilize a single strain
for the identification and characterization of virulence and immunity factors. Here, we describe significant variation between
A. fumigatus isolates in hypoxia fitness and virulence, highlighting the advantage of including multiple strains in future studies.
We also illustrate that hypoxia fitness correlates strongly with increased virulence exclusively in the nonleukopenic murine triamcinolone immunosuppression model of IPA. Through an experimental evolution experiment, we observe that chronic hypoxia exposure results in increased virulence of A. fumigatus. We describe here the first observation of a model-specific virulence
phenotype correlative with in vitro fitness in hypoxia and pave the way for identification of hypoxia-mediated mechanisms of
virulence in the fungal pathogen A. fumigatus.
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A

mong both eukaryotic and prokaryotic pathogens, including
the pathogenic fungus Aspergillus fumigatus, genomic analyses have revealed a startling level of genetic diversity within single
species (1–6). An emerging theme in fungal pathogenesis is the
extension of this characterization to intraspecies phenotypic heterogeneity. Of particular interest is variation in virulence across
clinical and environmental isolates, extending to laboratory
strains referenced as “wild-type” (“WT”) strains in pathogenesis
studies (7–11). For A. fumigatus, studies of phenotypic and virulence heterogeneity have been reported. These include reports of
variation in growth in vitro (12, 13) and virulence in multiple
animal models of aspergillosis, including a Drosophila melano-
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gaster model (12), murine models (14), and Galleria mellonella
larval models (15, 16). Comparisons between two commonly used
“WT” laboratory strains, CEA10 and AF293, have begun to reveal
differences in the immune response elicited by each strain (17).
While this research has started to highlight phenotypic heterogeneity across strains, causal connections between strain genetics, in
vitro phenotypes, and virulence have yet to be identified. Because
virulence is a multifaceted characteristic, both the complex environment of the host and specific factors of the pathogen should be
considered to identify mechanisms of pathogenesis and virulence
for each host-pathogen interaction (18). Although an ideal antifungal therapeutic would kill the fungus in any host context with®
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out extensive collateral damage, mechanistic insights into host
context-specific virulence mechanisms are expected to yield novel
therapeutic approaches in specific patient populations. To realize
this opportunity, the genotypic and phenotypic heterogeneities of
both the pathogen and host need to be understood. Consequently,
exploring intraspecies genotypic and phenotypic heterogeneity in
the A. fumigatus populations presents an exciting opportunity to
better understand the virulence of this important human pathogen and uncover novel therapeutic strategies in specific patient
populations.
The microenvironment of the lung in immunocompromised
hosts has been postulated to select for certain A. fumigatus genotypes and phenotypes, allowing the fungus to thrive in vivo, and
has been alluded to in competitive index studies and in the development of drug resistance in clinical strains (19–22). However,
the specific selective pressures of various ex vivo environments
that enable environmental isolates to better respond to the host
and increase virulence remain enigmatic (5, 19, 23). Several aspects of the host microenvironment that represent potential selective pressures have been characterized. These include alternations
in pH (24, 25), oxygen tensions (26, 27), and nutrient availability
(28, 29), among others. While great strides are being made toward
understanding how A. fumigatus responds to such stresses, utilizing multiple strains to elucidate mechanisms could significantly
enhance these efforts.
While assessing the mechanism of virulence across multiple
strains in vivo, it should be considered that the host microenvironment varies between susceptible populations of patients depending on the state and mechanism of immune suppression. This
creates an even more complex interplay of host-pathogen interactions and complicates the understanding of A. fumigatus responses to the host (30). While the majority of invasive pulmonary aspergillosis (IPA) cases have been reported among
neutropenic individuals, it has recently been recognized that the
number of nonneutropenic patients diagnosed with IPA is increasing (31, 32). This shift in IPA patient populations highlights
the relevance of the murine triamcinolone model of infection,
which presents a different in vivo microenvironment than the leukopenic (neutropenic) model (26, 30). For example, we have
described variability in tissue oxygen levels between these models, where pulmonary lesions in both models reach oxygen tensions below 1%; however, low oxygen (or hypoxic) lesions in
triamcinolone-treated mice, with increased host cell infiltrates,
encompass larger areas of tissue than those in leukopenic mice
(26).
The ability of A. fumigatus to adapt to low oxygen (or hypoxia)
is essential for virulence, as the master transcriptional regulator of
the hypoxia response in A. fumigatus, SrbA, is essential for growth
in hypoxia (⬍5% O2) in vitro and for virulence in both the triamcinolone and leukopenic murine models of IPA (33, 34). Considering the hypoxic nature of the infected lung, these data suggest
that the ability to adapt to low-oxygen environments is critical for
growth within the host and virulence. Therefore, we tested the
hypothesis that among a heterogeneous group of strains those
more fit in low-oxygen environments are more virulent.
Here, we report a strong correlation between in vitro hypoxic
growth phenotypes and A. fumigatus virulence. We observe that
the commonly utilized laboratory strains AF293 and CEA10 have
markedly different growth phenotypes in liquid culture under
normal-oxygen (normoxic) and low-oxygen (hypoxic) condi-

2

®

mbio.asm.org

tions. Strikingly, these two strains have a significant difference in
virulence in a triamcinolone murine model of IPA despite similar
virulence levels within a leukopenic (neutropenic) model. Therefore, we expanded our characterization of A. fumigatus strains
using a selection of environmental and clinical isolates to test
whether the ability to thrive under low oxygen conditions impacts
pathogenesis and virulence in the triamcinolone model of IPA.
Our characterization of these strains showed heterogeneity across
isolates in several in vitro growth phenotypes and a correlation
between higher hypoxia fitness and increased virulence in this
model. In further support of these observations, virulence of a
strain with low hypoxia fitness increases with experimental evolution through in vitro low-oxygen conditions, supporting a hypothesis that hypoxia fitness is a major factor in A. fumigatus virulence in specific host contexts.
RESULTS

Two common laboratory strains display virulence heterogeneity in a triamcinolone immunosuppression murine model and
varied fitness phenotypes in vitro. Heterogeneity between two
commonly used laboratory strains, AF293 and CEA10, has been
noted previously by our lab for qualitative hypoxia fitness in vitro
(35), but the importance of this observation has not been thoroughly explored. Given our previous data highlighting the role of
hypoxia fitness in A. fumigatus virulence, we sought to quantitatively measure in vitro fitness under various oxygen environments
for the two “WT” strains. To examine this, we measured radial
growth (Fig. 1A) and liquid biomass (Fig. 1B) of CEA10 and
AF293 in 1% glucose minimal medium (GMM) in normoxia (ambient air, ~21% O2) and hypoxia (0.2% O2). On solid medium in
hypoxia, CEA10 has significantly greater radial growth than
AF293 (P ⬍ 0.0001) (Fig. 1A). In liquid culture, we found that
biomass of AF293 is significantly increased (P ⫽ 0.0004) in normoxia compared to CEA10 after 48 h. Conversely, CEA10 produces more biomass after 48 h in hypoxia than AF293 (Fig. 1B). To
account for the ability of each individual strain to grow in hypoxia
relative to normoxia, we calculated the ratio of biomass in hypoxia
to biomass in normoxia (H/N) for each strain and observed that
the H/N fitness ratio of CEA10 is significantly (P ⫽ 0.0165) higher
than AF293 (Fig. 1C). We conclude that CEA10 has greater hypoxia fitness than AF293.
As we have previously observed extensive low oxygen regions
within pulmonary fungal lesions in the murine triamcinolone model
of IPA compared to the leukopenic model (26), we hypothesized that
the increased in vitro hypoxia fitness of CEA10 would allow for increased virulence in the murine triamcinolone model of IPA. In a
controlled side-by-side comparison, CEA10 is significantly (P ⫽
0.0002) more virulent than AF293 in this model of IPA as quantified
by murine mortality (Fig. 1D). However, consistent with previous
studies from several laboratories, in the chemotherapeutic model
(33), the two strains display nearly identical virulence levels (P ⫽
0.2426) as measured by murine mortality, where 90 to 100% of mice
succumb to infection by 12 days postinoculation (Fig. 1E). To evaluate the pathology of disease for each strain, we prepared lungs for
histological analysis from both models 3 days postinoculation (dpi).
Gomori methenamine silver (GMS) staining reveals greater fungal
load and denser fungal growth with CEA10 than with AF293 in the
triamcinolone and chemotherapeutic models of IPA (Fig. 1F and G).
It is also evident that CEA10 demonstrates increased lung parenchyma invasion, whereas AF293 is more often retained in larger air-
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FIG 1 Two common lab strains, CEA10 and AF293, show phenotypic variation and strikingly different virulence in a triamcinolone model of IPA but not a
leukopenic model of IPA. (A) Radial growth of CEA10 and AF293 on GMM in normoxia (~21% O2) and hypoxia (0.2% O2) at 96 h. (B) Biomass from liquid
cultures grown in 1% glucose minimal medium (GMM) in normoxia and hypoxia at 48 h. ***, P ⫽ 0.0004; n.s., not significant by unpaired, two-tailed t test. (C)
Ratio of biomass in hypoxia to biomass in normoxia, as calculated with values from panel B. *, P ⫽ 0.0165 by unpaired, two-tailed t test. (D) Survival analysis of
CEA10 (n ⫽ 20 from 2 independent experiments) and AF293 (n ⫽ 27 from 3 independent experiments) in a triamcinolone model of IPA in CD-1 mice inoculated
with 2 ⫻ 106 conidia intranasally. **, P ⫽ 0.0002 by log rank test. (E) Survival analysis of CEA10 (n ⫽ 16) and AF293 (n ⫽ 17) in a chemotherapeutic model of
IPA in CD-1 mice inoculated with 2 ⫻ 106 conidia intranasally. n.s., not significant by log rank test. (F and G) Hematoxylin and eosin (H&E) or Gomori
methenamine silver (GMS) stains of lungs 3 days postinoculation from triamcinolone-treated mice (F) and chemotherapy-treated leukopenic mice (G)
inoculated with 2 ⫻ 106 AF293 or CEA10 conidia. Images are representative of three mice, and all error bars indicate standard errors of the means.

ways. Staining with hematoxylin and eosin (H&E) illustrates increased inflammation for both strains in the triamcinolone model
compared to the chemotherapeutic model (Fig. 1F and G). Taken
together, these data highlight differences in in vivo fungal fitness and
the inflammatory response between these two laboratory “WT”
strains. Based on the observation that the significant increase in the
H/N growth ratio of CEA10 corresponds to its increased virulence in
the triamcinolone model of IPA, we hypothesized that H/N fitness
ratio could be used as a predictor of virulence across A. fumigatus
strains in the context of steroid-mediated immune suppression.
In vitro hypoxia fitness heterogeneity exists among clinical
and environmental isolates. To test our hypothesis that increased
hypoxia fitness might predict the virulence of A. fumigatus strains
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in an immunosuppression-dependent context, we expanded our
analysis to a random selection of A. fumigatus environmental and
clinical isolates confirmed through morphological analysis and
sequencing of the calmodulin gene and internal transcribed spacer
(ITS) region (data not shown). Four clinical isolates were collected through lung biopsies (M35662 and F78107) and bronchial
washes (F30186 and W73763), and 10 environmental isolates
were selected from broad geographic regions, including air samples (47-57, 47-60, and 47-9), an indoor hospital sample (47-4),
sawmill samples (47-10 and 47-7), and three samples from Netherlands (02-46, 02-10, and 02-30) (Table 1). The 10th environmental isolate is from a sputum sample (W72310) and is included among
the environmental isolates, as events of single isolation from sputum
®
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TABLE 1 Geographic origins of A. fumigatus isolates used in this study
Strain

Origin

Source

Lab “wild-type” strains
AF293
CEA10 (CBS144.89)

Lung biopsy specimen of neutropenic IPA patient
Patient with IPA

David Denning Laboratory
CBS-KNAW Fungal Biodiversity Centre

Environmental isolates
47-4 (AF250, FA210)
47-10 (AF221)
47–57 (AFIR957)
W72310
47-7 (AF217)
47-9 (AF70)
47-60 (AFRB3)
08-19-02-10 (02-10)
08-19-02-30 (02-30)
8-19-02-46 (02-46)

Salford Hope Hospital, Manchester, UK
Sawmill wood, New Zealand
Air sample, Dublin, Ireland
Sputum
Sawmill, Sweden
Air sample, NJ, USA
Air samples, Dublin, Ireland
Netherlands, Nijmegen
Netherlands, Berghem
Netherlands, Nijmegen

Paul Dyer, Nottingham, UK
Paul Dyer, Nottingham, UK
Paul Dyer, Nottingham, UK
Memorial Sloan Kettering, NY, USA
Paul Dyer, Nottingham, UK
Paul Dyer, Nottingham, UK
Paul Dyer, Nottingham, UK
Darius Armstrong, Imperial College London, London, UKa
Darius Armstrong, Imperial College London, London, UKa
Darius Armstrong, Imperial College London, London, UKa

Clinical isolates
M35662
F78107
F30186
W73763

Lung biopsy specimenb
Lung biopsy specimenb
Bronchial wash
Bronchial wash

Memorial Sloan Kettering, NY, USA
Memorial Sloan Kettering, NY, USA
Memorial Sloan Kettering, NY, USA
Memorial Sloan Kettering, NY, USA

a
b

See reference 75 for information on this Netherlands strain.
These are proven invasive aspergillosis based on modified EORTC criteria.

are often categorized as environmental contaminants during the collection process (36, 37). As observed with the two “WT” strains, there
is a range of fitness phenotypes among the clinical and environmental
isolates on solid medium and liquid biomass cultures in both normoxia and hypoxia (Fig. 2A, B, and C). Interestingly, the environmental isolates, in general, show greater variation in biomass under
both conditions than the clinical isolates (Fig. 2C). Taken together,
these data illustrate that significant hypoxia fitness heterogeneity exists across A. fumigatus strains.
To determine if strain heterogeneity extends to differences in
virulence, we assessed virulence of the respective environmental
and clinical isolates in the triamcinolone murine model of IPA.
Similarly to the in vitro phenotypic heterogeneity, the environmental isolates produce a spectrum of virulence, with median survival ranging from 12.5 (W72310) to 5.5 (47-4) dpi (Fig. 3A and
B). Among the clinical isolates, the median survival ranges from 5
(M35662) to 10 (F78107) dpi (Fig. 3C). Given that the difference
in virulence between CEA10 and AF293 is specific to the triamcinolone model, we assessed virulence of an isolate with hypovirulence in the triamcinolone model, 02-10, and an isolate with
hypervirulence in the triamcinolone model, 47-4, in the chemotherapeutic model. Similarly to the “WT” strains, we did not observe a
significant difference in virulence between the two isolates in this
leukopenic model (P ⫽ 0.1851 [Fig. 3D]). Taken together, these data
illustrate heterogeneity across A. fumigatus isolates in in vitro growth
phenotypes and virulence in a host-specific manner. We hypothesized that like the “WT” strains, the hypoxia fitness of these isolates
correlates with the virulence in the triamcinolone model of IPA.
A higher ratio of hypoxic to normoxic fitness correlates with
increased virulence in triamcinolone-treated mice. To test
whether there is a correlation between hypoxia fitness and virulence in the triamcinolone model of IPA, we determined the H/N
ratio of each isolate (Fig. 4A). Among the environmental isolates,
the H/N ratio varied from higher, CEA10-like ratios (47-4 and
47-10) to lower AF293-like ratios (W72310 and 02-10). The clin-

4

®

mbio.asm.org

ical isolates showed modest variation but interestingly were more
similar to each other than the environmental isolates and fell in
the middle range of the H/N ratios for CEA10 and AF293
(Fig. 4A). Spearman’s rank order correlation analysis, for nonparametric data (38), of the H/N fitness ratio versus the median
murine survival for each strain revealed a significant correlation
(Spearman’s rho, r ⫽ ⫺0.7867, P ⫽ 0.0003) between the two
metrics (Fig. 4B), supporting the hypothesis that increased fitness
in hypoxia yields higher virulence in the triamcinolone model of
IPA. If we separate isolates into distinct environmental and clinical groups and test the correlation of each group, both remain
significant, with a Spearman’s rho (r) of ⫺0.7031 (P ⫽ 0.0268) for
the environmental isolates (Fig. 4C) and a Spearman’s rho (r) of
⫺0.9429 (P ⫽ 0.0167 [Fig. 4D]) for the clinical isolates. As controls for nonnormalized growth, we included the Spearman correlation between hypoxic-only and normoxic-only biomass and
median survival. The correlations with hypoxia biomass (r ⫽
⫺0.6788; P ⫽ 0.0038 [Fig. 4E]) and normoxia biomass (r ⫽
0.5199; P ⫽ 0.0390 [Fig. 4F]) are both significant but are less
robust than the H/N correlation. However, it is important to note
that the correlation of normoxic biomass and median survival is
positive, indicating that increased growth capacity under normal
lab conditions negatively correlates with virulence in this cohort
of strains and murine model. Notably, this correlation is host specific, as there is no correlation between median survival in the
chemotherapeutic model and the H/N ratio (r ⫽ ⫺0.2582; P ⫽
0.75) with 02-10, 47-4, CEA10, and AF293 (data not shown).
Taken together, these data support a hypothesis that fitness in
hypoxia, not overall growth in normoxia, correlates with higher
virulence of A. fumigatus in the triamcinolone model of IPA and
that this correlation is host specific.
Interestingly, the environmental isolate 47-10 appears to be an
outlier within this correlation, displaying an increased median
survival compared to that predicted by the hypoxia fitness ratio.
Although correlations reveal connections between two pheno-
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types, they do not necessarily portray causal relationships. As virulence is a multifaceted characteristic, the outlier 47-10 may utilize alternative mechanisms that account for the high hypoxia
fitness without displaying the expected increase in virulence in the
triamcinolone model of IPA. Such strains, although outliers
within the correlation, can be informative in the identification of
traits influencing A. fumigatus virulence. One potential mechanism known to influence virulence and host immune responses is
cell wall polysaccharide microbe-associated molecular patterns
(MAMPs). Moreover, hypoxia is known to dramatically alter the
cell wall of A. fumigatus and Candida albicans (39, 40). However,
cell wall integrity analysis of these strains on the cell wallperturbing agents Congo red (CR) and calcofluor white (CFW) in
normoxia and hypoxia does not reveal any obvious phenotypes
correlative to virulence (see Fig. S1 in the supplemental material).
For example, 47-10 displayed increased resistance to Congo red
and CFW in normoxia and hypoxia, similarly to hypoxia-fit and
virulent strains 47-4 and CEA10. Ongoing work is focused on
uncovering the possible mechanisms of hypoxia-mediated virulence observed in the strains analyzed.
In vitro experimental evolution of a strain with low fitness in
hypoxia leads to increased virulence. With the observed correlation between virulence and fitness in hypoxia, we sought to experimentally test the hypothesis that increased fitness in hypoxia promotes virulence. Consequently, experimental evolution was
performed by serially passaging the laboratory “WT” strain
AF293, which exhibits low fitness in hypoxia (Fig. 1B) and attenuated virulence in the triamcinolone model of IPA (Fig. 1D). Following 20 passages in hypoxia, the resulting A. fumigatus strain,
named EVOL20, exhibits increased fitness in hypoxia as determined by colony diameter (P ⫽ 0.0026 [Fig. 5A]) and liquid biomass (P ⫽ 0.0448 [Fig. 5B]) compared to the parental strain. Interestingly, in normoxia, EVOL20 also displays increased colony
density and radial growth on solid medium at 96 h (Fig. 5A) but
displays significantly reduced biomass in normoxic liquid cultures
compared to AF293 (P ⫽ 0.0001 [Fig. 5B]). This increased fitness
results in a significantly (P ⫽ 0.0111) increased hypoxia fitness
ratio (H/N) of EVOL20 compared to AF293 (Fig. 5C). To determine whether this ratio correlates with increased virulence of the
strain, we used a low-dose (1 ⫻ 105 conidia) triamcinolone model
of IPA and observed that EVOL20 has a remarkably significant
increase in virulence over AF293 (P ⫽ 0.0296 [Fig. 5D]). Histology results from 3 dpi postinoculation reveal greater invasion of
EVOL20 into the lung parenchyma and a general increase in fungal growth and inflammation compared to lungs inoculated with
AF293 (Fig. 5E). Notably, the EVOL20 strain also displays increased virulence compared to AF293 in the chemotherapeutic
model of IPA (P ⫽ 0.0003); however, the median survival differs
only from day 4 for AF293 to day 3 for EVOL20 (Fig. 1E and 3D).
While the underlying mechanisms are an ongoing area of study,
these data suggest that increased hypoxia fitness promotes virulence in A. fumigatus.
FIG 2 Clinical and environmental isolates show heterogeneity in hypoxic
growth. (A) Radial growth of clinical and environmental isolates on GMM
under normoxia and hypoxia conditions. (B and C) Four clinical isolates,
M35662, F78107, F30186, and W73763 (n ⫽ 4) (B), and the remaining environmental isolates (n ⫽ 10) (C) reveal heterogeneity in biomass from liquid
culture in normoxia (~21% O2) and hypoxia (0.2% O2). Data are presented as
the means from biological triplicates with error bars representing standard
errors of the means.
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FIG 3 Clinical and environmental isolates present a spectrum of virulence in the triamcinolone model of IPA but not in a chemotherapeutic model. (A and B)
Data are separated into two distinct graphs for easy viewing. Triamcinolone-treated CD-1 mice inoculated with 2 ⫻ 106 conidia of 02-10 (n ⫽ 12), 47-9 (n ⫽ 11),
02-30 (n ⫽ 12), 47-10 (n ⫽ 16), 47-4 (n ⫽ 16), 47-60 (n ⫽ 12), 47-7 (n ⫽ 12), 02-46 (n ⫽ 13), W72310 (n ⫽ 16), or 47-57 (n ⫽ 16) reveal a range of virulence
levels across the isolates. (C) Clinical isolates (n ⫽ 16 per strain) inoculated in triamcinolone-treated CD-1 mice at 2 ⫻ 106 conidia reveal reduced heterogeneity
in virulence (curves not significantly different by log rank test; P ⫽ 0.2296). (D) Survival of mice treated with both cyclophosphamide and triamcinolone
(chemotherapeutic model) were inoculated with 2 ⫻ 106 conidia of 47-4, 02-10, or EVOL20 (n ⫽ 12 per strain). In this model, all three strains produce curves
that are indistinguishable from one another (log rank, P ⫽ 0.1851 for 47-4 and 02-10).

DISCUSSION

The use of a single strain for the study of pathogenesis and
virulence is a common practice in the field of molecular pathogenesis and immunity; however, the increased appreciation for
dramatic intraspecies heterogeneity suggests the need to include multiple strains in such studies of virulence. Besides the
known clinical implications of pathogen heterogeneity, intraspecies variation provides an outstanding opportunity to better
define the virulence mechanisms of a given microbial species.
A. fumigatus strains, including WT reference strains, clinical
isolates, and environmental isolates, have previously been
shown to have significant genetic diversity and to display phenotypic heterogeneity in vitro and in vivo (3, 12–17, 41). Currently, two studies have proposed correlations between A. fumigatus isolates, describing a relationship between normoxic
fungal growth rate and virulence in the murine neutropenic
model of IPA (n ⫽ 9) (42) and between gliotoxin production
and virulence in the G. mellonella model of IPA (n ⫽ 4) (43).
However, such studies utilize a relatively low number of exclusively clinical A. fumigatus isolates and do not extend the analyses to the diverse group of environmental isolates or virulence
in multiple host contexts. Therefore, further analysis of such
mechanisms of virulence in a diverse group of isolates may
highlight strain-specific virulence factors and host-adaptation
strategies, as well as strain-specific host responses, such as
those observed between the two “WT” reference strains of
A. fumigatus, CEA10 and AF293 (44, 45). Heterogeneity in virulence has been observed for several other pathogenic fungi,
including Cryptococcus neoformans (46), Paracoccidioides
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brasiliensis (47, 48), C. albicans (49), and Histoplasma capsulatum
(50); however, for most fungi, the possible contributing mechanisms have yet to be fully defined. Laboratory passaging of C. neoformans serotype A strain H99 results in genomic alterations yielding several phenotypically diverse lineages, several of which are
avirulent (46). Similarly, P. brasiliensis isolates are also reported to
display virulence heterogeneity, and individual isolates lose virulence as a result of in vitro laboratory passaging (47), partially as a
result of reduced ␣-1,3-glucan content of the cell wall (48). Moreover, virulence and in vivo phenotypic heterogeneities have also
been observed in subsets of C. albicans strains characterized by
white or opaque colonies (49). These observations of phenotypic
and virulence heterogeneity in medically important fungi highlight the broad implications of recognizing diversity within a species and underscore the opportunity to define novel mechanisms
of virulence in multiple strains of A. fumigatus.
Here, we report significant heterogeneity in A. fumigatus virulence between two widely used laboratory “WT” strains, AF293
and CEA10, in the triamcinolone murine model of IPA. This significant difference in virulence between the two strains is dependent on the host immune status, as the strains display nearly identical virulence levels in a murine chemotherapeutic model of IPA,
where the host is largely leukopenic. This is not the first instance of
reported variation between these two strains, as Rizzetto and colleagues (17) reported a number of differences between them in an
immunocompetent murine model, which included differences
in the inflammatory response and increased pulmonary fungal
burden and mortality in CEA10-challenged mice compared to
AF293-challenged mice. Analysis of the cytokine profiles induced
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FIG 4 Higher ratio of hypoxia-to-normoxia biomass correlates with increased virulence in the triamcinolone model of IPA. (A) Ratio of liquid culture biomass
in hypoxia (0.2% O2) to normoxia (~21% O2) for environmental and clinical isolates. (B to D) Spearman rank order correlations calculated from H/N ratio and
median survival (n ⫽ 16; r ⫽ ⫺0.7867; P ⫽ 0.0003) for all strains (B) (clinical isolates [diamonds], lab-utilized “WT” strains [squares], and environmental
isolates [circles]) and separated by environmental (n ⫽ 10; r ⫽ ⫺0.7031; P ⫽ 0.0268) (C) and clinical (n ⫽ 6; r ⫽ ⫺0.9429; P ⫽ 0.0390) (D) isolates. (E and F)
Spearman rank order correlations and median survival for all 16 strains of hypoxia-only biomass (r ⫽ ⫺0.6788; P ⫽ 0.0038) (E) and normoxia-only biomass (r ⫽
0.5199; P ⫽ 0.0390) (F).

by each strain revealed that CEA10 elicits a more potent
interleukin-17 (IL-17) response by dendritic cells in vitro and in
the immunocompetent murine model, while AF293 drives a
higher production of IL-10, IL-1␤, and gamma interferon
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(IFN-␥), further suggesting that the immune response during an
infection is strain dependent (17).
Comparisons of these strains at the genome level reveal that
although 98% of each genome can be aligned with high identity
®
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FIG 5 Serial passaging of a strain with low hypoxia fitness increases growth and virulence in triamcinolone-treated mice. (A and B) Radial growth (A) and liquid

biomass (B) on GMM in normoxia (~21% O2) and hypoxia (0.2% O2). ***, P ⫽ 0.0001; *, P ⫽ 0.0448, by unpaired, two-tailed t test. (C) Ratio of hypoxia biomass
to normoxia biomass for EVOL20 compared to the parental AF293 strain. *, P ⫽ 0.0111 by unpaired, two-tailed t test. (D) Survival analysis with a low-dose
inoculum (1 ⫻ 105 conidia) in the triamcinolone-treated CD-1 mice (*, P ⫽ 0.0296 by log rank test; n ⫽ 10 per strain). (E) Hematoxylin and eosin (H&E) or
Gomori methenamine silver (GMS) stains of lungs 3 days postinoculation from triamcinolone-treated CD-1 mice inoculated with 1 ⫻ 105 conidia. Images are
representative of 3 mice.

(99.3 to 99.8%), 1.4% and 2.3% of AF293 and CEA10, respectively, harbor unique genes. Furthermore, 41 orthologous gene
pairs between the two strains do not share 100% identity, and
alignment of some of these genes shows identities as low as 37%
(51). Taken together, the influence of the variable host environment and the genetic heterogeneity of A. fumigatus strains pres-
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ents multiple opportunities to better understand causative mechanisms underlying virulence in the increasingly common
nonneutropenic patient population.
Building upon the known heterogeneity in these “WT” strains,
our study demonstrates that AF293 and CEA10 have significantly
different fitness levels in low-oxygen (hypoxic) environments
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when normalized to their fitness in normal-oxygen (normoxic)
environments. This ratio of hypoxia fitness correlates with the
significant variation in virulence between these two strains.
CEA10 not only is more virulent in the triamcinolone murine
model of IPA but also displays significantly increased hypoxia
fitness as measured by total biomass and colony diameter. This
observation led us to hypothesize that increased hypoxia fitness
drives increased virulence in host contexts characterized by extensive hypoxia at the site of infection. Hypoxia is a known characteristic of host microenvironments for infections caused by pathogenic organisms, including Mycobacterium tuberculosis and
Histoplasma capsulatum (52–55). Hypoxic lesions have been observed in several tuberculosis animal models, including rats,
guinea pigs, rabbits, and nonhuman primates (53, 55), and have
been suggested to serve as a trigger for M. tuberculosis bacteriostasis, a critical stage of dormancy in M. tuberculosis pathology (56).
Moreover, H. capsulatum causes lesions in the murine liver that
contain regions of hypoxic tissue and is able to grow in vitro at
oxygen tensions below 1% (52). We have previously shown hypoxia to also be a component of the murine pulmonary microenvironment during IPA with both the triamcinolone and chemotherapeutic models of immune suppression. Lesions in both
models reach tensions likely well below 1% O2; however, the
triamcinolone-treated mice present with larger and more severe
hypoxic lesions than those in the chemotherapeutic model (26).
In order to thrive in such an oxygen-limiting environment,
A. fumigatus requires the sterol regulatory element-binding protein (SREBP) transcription factor SrbA. We have previously
shown SrbA to be essential for A. fumigatus virulence and in vitro
hypoxic growth (33, 34). The requirement for an SREBP transcription factor in virulence is not unique to A. fumigatus, as the
SrbA homolog, Sre1, of C. neoformans is essential for formation of
brain lesions in a murine model of cryptococcosis (27, 57). Further, transcriptional analysis of H. capsulatum in hypoxia in vitro
revealed an upregulated profile of genes with binding sites consistent with conserved SREBP motifs, suggesting an SrbA/Sre1-like
hypoxia response such as those characterized in A. fumigatus and
C. neoformans (52). Thus, we conclude that hypoxia is an important feature of several host-pathogen interactions, and a pathogen’s ability to cope with this environmental stress is essential for
virulence.
Given the observed differences between commonly utilized
“WT” reference strains, we expanded our analysis to include several environmental and clinical isolates to test the hypothesis that
increased hypoxia fitness correlates with increased virulence in the
triamcinolone model of IPA. We chose 10 environmental isolates,
collected from various geographic and ecological niches, and four
clinical isolates (Table 1). Interestingly, across these isolates,
greater variation in hypoxia fitness was observed among the 10
environmental isolates than among the four clinical isolates. This
reduced variation among the clinical isolates may be the result of
the intense oxygen-mediated selective pressures within the host.
Notably, the clinical isolates do not cluster based on isolation
strategies, i.e., bronchial wash versus lung biopsy. Comparing the
virulence levels of these clinical and environmental isolates, it becomes clear that virulence in the triamcinolone model, as measured by median survival, correlates strongly with A. fumigatus
normoxia-normalized hypoxic fitness (H/N) in liquid culture.
Importantly, this correlation applies only to the triamcinolone
model of IPA and is not present in the chemotherapeutic model,
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indicating that hypoxia fitness is a virulence determinant specific
to the host immune status.
In support of this correlation between hypoxic fitness and virulence, experimental evolution was performed with AF293 and
resulted in a strain, EVOL20, which displays increased hypoxia
fitness and, importantly, increased virulence in the triamcinolone
model of IPA. Similar in vivo and ex vivo laboratory passaging
experiments have proved insightful in studies of other pathogenic
fungi, including Candida species and C. neoformans (58–60). The
ability of the A. fumigatus evolved strain (EVOL20) to develop
increased hypoxia fitness from in vitro exposure not only highlights a role for environmental influence on the heterogeneity of
A. fumigatus strains but demonstrates the strong selective pressure
of altered oxygen tensions for highly virulent strains. It is possible
that natural environmental conditions, with various oxygen tensions, can generate genetic and phenotypic alterations that predispose some environmental strains to thrive within the host, accounting for at least a portion of the virulence heterogeneity that
we have reported. Given the vast environments from which A. fumigatus is isolated (water, air, soil, compost, etc.), the various
selective pressures of the environments may partially explain the
greater variation in phenotypes that we observe among the environmental isolates compared to the clinical isolates. Work is ongoing to characterize the molecular mechanisms responsible for
the increased growth in hypoxia and increased virulence of the
hypoxia-evolved strain EVOL20.
Correlation analyses such as these illustrate a relationship between two phenotypes; however, it does not reveal the causal
mechanisms. However, hypoxia acts through several possible
mechanisms that may explain the correlation between hypoxia
fitness and virulence in the triamcinolone model of IPA. The effects of hypoxia on fungal biology are broad, including changes to
virulence-associated mechanisms such as the cell wall (39), cellular metabolism (61–63), iron homeostasis (63, 64), stress mitigation, and responses to host immune cells (39) (Fig. 6). The cell wall
directly interacts with the host, and in the triamcinolone model of
IPA, where immune cells can drive a hyperinflammatory response
to A. fumigatus that may result in host damage, this interface is an
obvious candidate to drive differences in virulence across strains.
Previous studies have shown that growth in hypoxia results in
thickening of the cell wall with increased ␤-glucan exposure, and
cells grown in hypoxia elicit a more potent inflammatory response
from immune cells (39). While we did not observe any obvious
patterns of differential susceptibility to cell wall-perturbing agents
across our isolates under hypoxic conditions, detailed cell wall
composition analyses and MAMP exposure are needed to explore
this hypothesis further. Hypoxia also affects cellular metabolism
of A. fumigatus, increasing the transcription and translation of
glycolytic enzymes (62, 63) and the use of fermentative pathways
(65) while decreasing mitochondrial respiration (61). Evidence in
Saccharomyces cerevisiae suggests that decreased electron flux
through the electron transport chain paradoxically increases the
generation of reactive oxygen species (ROS) within the cell (66);
thus, mechanisms to deal with redox stresses under hypoxia are
required. To this end, the activity of the alternative oxidase is
increased in hypoxia, offering a potential mechanism to combat
an increase in cellular ROS under these conditions (61). Hypoxia
also affects metal ion metabolism, with increased transcription of
iron acquisition pathways (64) and increased iron and other critical metal content in cells under low-oxygen conditions (63).
®
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FIG 6 Hypoxia influences a myriad of biological processes in A. fumigatus and the host. Hypoxia has been shown to impact several key factors, many of which
have identified roles in virulence. Transcriptomics reveals increased expression of glycolytic enzymes as well as enzymes of the ␥-aminobutyrate (GABA) shunt
(62). Hypoxia has been shown to cause thickening of the cell wall with increased exposure of ␤-glucan (39). Ergosterol biosynthesis and iron homeostasis are also
transcriptionally influenced by hypoxia (64), and increased iron content in the fungi has been demonstrated under hypoxic conditions (63). Last, the cellular
response to reactive oxygen species and endoplasmic reticulum stress is altered in hypoxia as shown by increased alternative oxidase activity (AOX) (61) and a
hypoxic growth defect in ⌬ireA (74). UPR, unfolded protein response. Hypoxia-mediated host changes include increased neutrophil recruitment, survival, and
effector functions through activation of HIF-1␣.

These cellular changes, as well as potential unexplored effects of
hypoxia, represent possible mechanisms that drive virulence in
strains that are well adapted to low-oxygen conditions, and each
strain may employ one or several of these mechanisms to thrive
within the host environment. Thus, further studies are warranted
to understand the causative links between hypoxia and virulence
and how these links vary between strains.
In addition to these effects of hypoxia on A. fumigatus, low
oxygen also affects the host response through modulation of host
cell function. Hypoxia has a myriad of known effects on myeloid
cell function, including the well-studied effects of the hypoxiainducible transcription factor HIF-1␣. HIF-1␣ coordinates the
cellular response to low-oxygen stress, such as that encountered
by neutrophils in the hypoxic microenvironment of infected tissues. In particular, HIF-1␣ regulates neutrophil recruitment
down an oxygen gradient to regions of low-oxygen tensions
through the upstream regulation of ␤2-integrin-mediated diapedesis (67). Once at the hypoxic lesion, the critical survival of neutrophils is also HIF-1␣ coordinated, as demonstrated by reduced
survival of HIF-1␣-deficient neutrophils following in vitro hypoxia exposure (68). Hypoxia has also been shown to have HIF-1␣dependent effects on neutrophil effector function through regulation of phagocytosis and bactericidal activity (69). We have also
previously shown that HIF-1␣ is required for host protection
against IPA, due to inefficient neutrophil recruitment at the site of
infection (70). Intriguingly, triamcinolone treatment strongly reduces HIF-1␣ nuclear levels and target gene expression in the lung
during A. fumigatus challenge (70). Together, the effects of low
oxygen on fungal and host-specific processes and the hostpathogen interactions shape the disease progression, severity, and
outcome of a given host. Therefore, the specific host environment,
in conjunction with fungal genotype and phenotype, must be considered when assessing the host-pathogen interaction.
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The correlation between the hypoxic growth and virulence of
A. fumigatus strains not only highlights the clinically relevant heterogeneity between A. fumigatus isolates from the environment
and the clinic but also suggests a role for the selective pressures of
the environment on the virulence of the organism, where those
environments that are oxygen poor may select for strains that are
better able to thrive in the hypoxic microenvironment of the infected lung. These data also serve to illustrate that IPA pathology
may be directly influenced by the strain of A. fumigatus and that
the pathology of infection cannot be described merely in terms of
the host status and immune response as described previously (71).
Future work in A. fumigatus virulence studies should consider
strain variation in identification of virulence determinants to encompass a clinically relevant cohort of isolates and expand opportunities to develop novel therapeutic approaches in specific
patient-fungal interactions.
MATERIALS AND METHODS
Strains and media. Strains used in this study are listed in Table 1. All
strains were stored as conidial suspensions in 50% glycerol at ⫺80°C.
Strains were grown on 1% glucose minimal medium (GMM) (72) at 37°C,
and conidia were collected in 0.01% Tween for in vitro assays. For animal
studies, spores were collected in 0.01% Tween and then resuspended in
sterile phosphate-buffered saline (PBS). For all solid media, 1.5% agar was
added prior to autoclaving.
Serial passaging of A. fumigatus AF293 through a low-oxygen environment. The “WT” lab-adapted strain AF293 was grown for 4 days at
37°C in 0.2% O2 and 5% CO2 on GMM without FeSO4·7H2O to mimic
the oxygen- and nutrient-poor microenvironment of the host. The population of conidia was then subcultured/passaged for 20 generations for a
total of 80 days of hypoxic growth. The population of conidia was then
single spored, and a single spore was selected based on fitness in hypoxia
for further analyses. This strain, EVOL20, was maintained under the passaging conditions prior to further analyses.
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Growth assays. Radial growth was quantified by point inoculating 103
conidia on GMM plates at 37°C in normoxia (~21% O2, 5% CO2) and
hypoxia (0.2% O2, 5% CO2). Colony diameter was measured every 24 h
for 4 days and reported as the average from three biological replicates per
strain. Fungal biomass was quantified by measuring the dry weight of
fungal tissue from 5 ⫻ 107 conidia grown in 100 ml liquid GMM with
shaking at 200 rpm for 48 h in normoxia (~21% O2) and hypoxia (0.2%
O2, 5% CO2). Liquid biomass is reported as the average from three biological replicates per strain. Hypoxic conditions were maintained using an
Invivo2 400 hypoxia workstation (Ruskinn Technology Limited, Bridgend, United Kingdom) with a gas regulator and 94.8% N2.
Cell wall-perturbing agents. Serial dilutions of conidia were prepared
to create dilutions of 105 conidia to 102 conidia/2 l. Conidial dilutions
were plated on GMM containing 1 mg/ml Congo red (Sigma; catalog no.
C6277) or 25 g/ml calcofluor white (fluorescent brightener 28; Sigma;
catalog no. F3543). Plates were incubated in normoxia (~21% O2, 5%
CO2) or hypoxia (~0.2% O2, 5% CO2) for 48 h. Images are representative
of biological triplicates.
Survival analysis. The virulence of the A. fumigatus strains was assessed in two murine models of IPA, the chemotherapeutic model and the
triamcinolone model. Mice were housed in autoclaved cages at 4 mice per
cage with HEPA-filtered air and autoclaved food and water available ad
libitum. For the chemotherapeutic murine model, outbred CD-1 female
mice (Charles River Laboratories, Raleigh, NC), 6 to 8 weeks old, were
immunosuppressed with intraperitoneal (i.p.) injections of cyclophosphamide (Baxter Healthcare Corporation, Deerfield, IL) at 150 mg/kg of
body weight 48 h before fungal inoculation and 72 h after fungal inoculation, along with subcutaneous (s.c.) injections of 40 mg/kg Kenalog-10
(triamcinolone acetonide; Bristol-Myer Squibb, Princeton, NJ) 24 h before fungal inoculation and 6 days after fungal inoculation. For the murine triamcinolone model, outbred CD-1 female mice, 6 to 8 weeks old,
were treated with 40 mg/kg Kenalog-10 by s.c. injection 24 h prior to
fungal inoculation.
For both murine models with the “WT,” environmental, and clinical
isolates, conidial suspensions of 2 ⫻ 106 conidia were prepared in 40 l
sterile PBS and administered to mice intranasally while under isoflurane
anesthesia. Mock mice were given 40 l PBS without fungal spores. Mice
were monitored three times a day for signs of disease for 14 days postinoculation. Virulence of EVOL20 and parental AF293 inocula from passaging conditions was assessed in the triamcinolone murine model, where
mice were immunosuppressed as previously described and received a lowdose conidial suspension of 105 conidia in 40 l sterile PBS 24 h after
Kenalog-10 injection. Survival was plotted on Kaplan-Meier curves, and
statistical significance between curves was determined using the MantelCox log rank.
Histopathology. Outbred CD-1 mice, 6 to 8 weeks old, were immunosuppressed and intranasally inoculated with conidia as described above
for the chemotherapeutic and corticosteroid murine models. Three mice
in each group were inoculated with either 2 ⫻ 106 AF293 conidia, 2 ⫻ 106
CEA10 conidia, 1 ⫻ 105 EVOL20 conidia, or 1 ⫻ 105 AF293 conidia from
the passaging conditions as described above. Mice were sacrificed 72 h
postinoculation. Lungs were perfused with 10% buffered formalin phosphate before removal and then stored in 10% buffered formalin phosphate until embedding. Paraffin-embedded sections were stained with
hematoxylin and eosin (H&E) and Gomori methenamine silver (GMS).
Slides were analyzed microscopically with a Zeiss Axioplan 2 imaging
microscope (Carl Zeiss Microimaging, Inc., Thornwood, NY) fitted with a
QImaging Retiga-SRV Fast 1394 RGB camera. Analysis was performed
with Phylum Live 4 imaging software.
Ethics statement. We carried out our animal studies in strict accordance with the recommendations in the Guide for the Care and Use of
Laboratory Animals (73). The animal experimental protocol was approved
by the Institutional Animal Care and Use Committee (IACUC) at Dartmouth, College (federal-wide assurance number A3259-01).
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Statistics and correlation analysis. All statistical analyses were done
with Prism 5 software (GraphPad Software Inc., San Diego, CA). Correlations were calculated using the Spearman rank order correlation analysis
for nonparametric data. All error bars represent standard errors of the
means.

SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.01515-16/-/DCSupplemental.
Figure S1, TIF file, 15.8 MB.

ACKNOWLEDGMENTS
Research in this study was funded also in part by NIH R01 AI081838
(R.A.C.). J.J.O. and R.A.C. were supported in part by institutional startup
funds and in part through the Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research grant P30 GM106394 (principal investigator, Bruce A. Stanton) and Center for Molecular, Cellular
and Translational Immunological Research grant P30 GM103415 (principal investigator, William R. Green). This work was funded in part by
NIH R01 AI093808 and R21 AI105617 grants to T.M.H. and in part
through the NIH/NCI Cancer Center Support grant P30 CA008748 to
MSKCC. R.A.C. and T.M.H. are Investigators in the Pathogenesis of Infectious Diseases supported by the Burroughs Wellcome Fund. The
funders had no role in the preparation or publication of the manuscript.
We thank Jay Dunlap and Jennifer Loros for valuable advice on the
manuscript. We thank Dr. Darius Armstrong and Dr. Paul Dyer for graciously providing strains for these studies.

FUNDING INFORMATION
This work, including the efforts of Robert A Cramer, was funded by HHS
| NIH | National Institute of Allergy and Infectious Diseases (NIAID) (R01
AI081838). This work, including the efforts of Tobias Hohl, was funded by
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
(R01 AI093808). This work, including the efforts of Tobias Hohl and
Robert A Cramer, was funded by Burroughs Wellcome Fund (BWF).
EM supported by New Hampshire-INBRE through an Institutional Development Award (IDeA), P20GM103506, from the National Institute of
General Medical Sciences of the NIH.

REFERENCES
1. Debeaupuis JP, Sarfati J, Chazalet V, Latgé JP. 1997. Genetic diversity
among clinical and environmental isolates of Aspergillus fumigatus. Infect
Immun 65:3080 –3085.
2. Rath PM, Ratjen F, Ansorg R. 1997. Genetic diversity among isolates of
Aspergillus fumigatus in patients with cystic fibrosis. Zentralbl Bakteriol
285:450 – 455. http://dx.doi.org/10.1016/S0934-8840(97)80012-6.
3. Araujo R, Amorim A, Gusmão L. 2010. Genetic diversity of Aspergillus
fumigatus in indoor hospital environments. Med Mycol 48:832– 838.
http://dx.doi.org/10.3109/13693780903575360.
4. Duarte-Escalante E, Zúñiga G, Ramírez ON, Córdoba S, Refojo N,
Arenas R, Delhaes L, Reyes-Montes MDR. 2009. Population structure
and diversity of the pathogenic fungus Aspergillus fumigatus isolated from
different sources and geographic origins. Mem Inst Oswaldo Cruz 104:
427– 433. http://dx.doi.org/10.1590/S0074-02762009000300005.
5. Rosehart K, Richards MH, Bidochka MJ. 2002. Microsatellite analysis of
environmental and clinical isolates of the opportunist fungal pathogen
Aspergillus fumigatus. J Med Microbiol 51:1128 –1134. http://dx.doi.org/
10.1099/0022-1317-51-12-1128.
6. Katz ME, McLoon M, Burrows S, Cheetham BF. 1998. Extreme DNA
sequence variation in isolates of Aspergillus fumigatus. FEMS Immunol
Med Microbiol 20:283–288. http://dx.doi.org/10.1111/j.1574
-695X.1998.tb01138.x.
7. Beale MA, Sabiiti W, Robertson EJ, Fuentes-Cabrejo KM, O’Hanlon
SJ, Jarvis JN, Loyse A, Meintjes G, Harrison TS, May RC, Fisher MC,
Bicanic T. 2015. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa. PLoS Negl Trop Dis 9:e0003847. http://dx.doi.org/10.1371/
journal.pntd.0003847.

®

mbio.asm.org 11

Kowalski et al.

8. Luo S, Hipler UC, Münzberg C, Skerka C, Zipfel PF. 2015. Sequence
variations and protein expression levels of the two immune evasion
proteins Gpm1 and Pra1 influence virulence of clinical Candida albicans isolates. PLoS One 10:e0113192. http://dx.doi.org/10.1371/
journal.pone.0113192.
9. Hirakawa MP, Martinez DA, Sakthikumar S, Anderson MZ, Berlin A,
Gujja S, Zeng Q, Zisson E, Wang JM, Greenberg JM, Berman J, Bennett
RJ, Cuomo CA. 2015. Genetic and phenotypic intra-species variation in
Candida albicans. Genome Res 25:413– 425. http://dx.doi.org/10.1101/
gr.174623.114.
10. Halliwell SC, Smith MC, Muston P, Holland SL, Avery SV. 2012.
Heterogeneous expression of the virulence-related adhesin Epa1 between
individual cells and strains of the pathogen Candida glabrata. Eukaryot
Cell 11:141–150. http://dx.doi.org/10.1128/EC.05232-11.
11. Alanio A, Desnos-Ollivier M, Dromer F. 2011. Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background
influences outcome during cryptococcal meningoencephalitis in humans.
mBio 2:e00158-11. http://dx.doi.org/10.1128/mBio.00158-11.
12. Ben-Ami R, Lamaris GA, Lewis RE, Kontoyiannis DP. 2010. Interstrain
variability in the virulence of Aspergillus fumigatus and Aspergillus terreus
in a toll-deficient Drosophila fly model of invasive aspergillosis. Med Mycol 48:310 –317. http://dx.doi.org/10.1080/13693780903148346.
13. Leslie CE, Flannigan B, Milne LJ. 1988. Morphological studies on clinical
isolates of Aspergillus fumigatus. J Med Vet Mycol 26:335–341. http://
dx.doi.org/10.1080/02681218880000481.
14. Mondon P, De Champs C, Donadille A, Ambroise-Thomas P, Grillot R.
1996. Variation in virulence of Aspergillus fumigatus strains in a murine
model of invasive pulmonary aspergillosis. J Med Microbiol 45:186 –191.
http://dx.doi.org/10.1099/00222615-45-3-186.
15. Alshareef F, Robson GD. 2014. Genetic and virulence variation in an
environmental population of the opportunistic pathogen Aspergillus fumigatus. Microbiology 160:742–751. http://dx.doi.org/10.1099/
mic.0.072520-024464798.
16. Cheema MS, Christians JK. 2011. Virulence in an insect model differs
between mating types in Aspergillus fumigatus. Med Mycol 49:202–207.
http://dx.doi.org/10.3109/13693786.2010.512301
17. Rizzetto L, Giovannini G, Bromley M, Bowyer P, Romani L, Cavalieri
D. 2013. Strain dependent variation of immune responses to A. fumigatus:
definition of pathogenic species. PLoS One 8:e56651. http://dx.doi.org/
10.1371/journal.pone.0056651.
18. Binnewies TT, Motro Y, Hallin PF, Lund O, Dunn D, La T, Hampson
DJ, Bellgard M, Wassenaar TM, Ussery DW. 2006. Ten years of bacterial
genome sequencing: comparative-genomics-based discoveries. Funct Integr Genomics 6:165–185. http://dx.doi.org/10.1007/s10142-006-0027-2.
19. Hagiwara D, Takahashi H, Watanabe A, Takahashi-Nakaguchi A,
Kawamoto S, Kamei K, Gonoi T. 2014. Whole-genome comparison of
Aspergillus fumigatus strains serially isolated from patients with aspergillosis. J Clin Microbiol 52:4202– 4209. http://dx.doi.org/10.1128/
JCM.01105-14.
20. Amich J, Schafferer L, Haas H, Krappmann S. 2013. Regulation of
sulphur assimilation is essential for virulence and affects iron homeostasis
of the human-pathogenic mould Aspergillus fumigatus. PLoS Pathog
9:e1003573. http://dx.doi.org/10.1371/journal.ppat.1003573.
21. Brown JS, Aufauvre-Brown A, Brown J, Jennings JM, Arst H, Jr.,
Holden DW. 2000. Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity. Mol Microbiol 36:1371–1380. http://dx.doi.org/10.1046/j.1365
-2958.2000.01953.x.
22. Krappmann S, Bignell EM, Reichard U, Rogers T, Haynes K, Braus GH.
2004. The Aspergillus fumigatus transcriptional activator CpcA contributes significantly to the virulence of this fungal pathogen. Mol Microbiol
52:785–799. http://dx.doi.org/10.1111/j.1365-2958.2004.04015.x.
23. Movahed E, Munusamy K, Tan GM, Looi CY, Tay ST, Wong WF. 2015.
Genome-wide transcription study of Cryptococcus neoformans H99 clinical strain versus environmental strains. PLoS One 10:e0137457. http://
dx.doi.org/10.1371/journal.pone.0137457.
24. Bignell E, Negrete-Urtasun S, Calcagno AM, Haynes K, Arst HN, Jr,
Rogers T. 2005. The Aspergillus pH-responsive transcription factor PacC
regulates virulence. Mol Microbiol 55:1072–1084. http://dx.doi.org/
10.1111/j.1365-2958.2004.04472.x.
25. Selvig K, Alspaugh JA. 2011. pH response pathways in fungi: adapting to
host-derived and environmental signals. Mycobiology 39:249 –256. http://
dx.doi.org/10.5941/MYCO.2011.39.4.249.

12

®

mbio.asm.org

26. Grahl N, Puttikamonkul S, Macdonald JM, Gamcsik MP, Ngo LY, Hohl
TM, Cramer RA. 2011. In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosis. PLoS
Pathog 7:e1002145. http://dx.doi.org/10.1371/journal.ppat.1002145.
27. Chun CD, Liu OW, Madhani HD. 2007. A link between virulence and
homeostatic responses to hypoxia during infection by the human fungal
pathogen Cryptococcus neoformans. PLoS Pathog 3:e22. http://
dx.doi.org/10.1371/journal.ppat.0030022.
28. Cooney NM, Klein BS. 2008. Fungal adaptation to the mammalian host:
it is a new world, after all. Curr Opin Microbiol 11:511–516. http://
dx.doi.org/10.1016/j.mib.2008.09.018.
29. Haas H, Eisendle M, Turgeon BG. 2008. Siderophores in fungal physiology and virulence. Annu Rev Phytopathol 46:149 –187. http://
dx.doi.org/10.1146/annurev.phyto.45.062806.094338.
30. Dagenais TR, Keller NP. 2009. Pathogenesis of Aspergillus fumigatus in
invasive aspergillosis. Clin Microbiol Rev 22:447– 465. http://dx.doi.org/
10.1128/CMR.00055-08.
31. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic
C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S,
Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP. 2006.
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year
survey. Clin Infect Dis 43:577–584. http://dx.doi.org/10.1086/505870.
32. Russo A, Falcone M, Vena A, Venditti C, Mancini C, Morelli A,
Venditti M. 2011. Invasive pulmonary aspergillosis in non-neutropenic
patients: analysis of a 14-month prospective clinical experience. J Chemother 23:290 –294. http://dx.doi.org/10.1179/joc.2011.23.5.290.
33. Willger SD, Puttikamonkul S, Kim KH, Burritt JB, Grahl N, Metzler
LJ, Barbuch R, Bard M, Lawrence CB, Cramer RA, Jr. 2008. A
sterol-regulatory element binding protein is required for cell polarity,
hypoxia adaptation, azole drug resistance, and virulence in Aspergillus
fumigatus. PLoS Pathog 4:e1000200. http://dx.doi.org/10.1371/
journal.ppat.1000200.
34. Willger SD, Cornish EJ, Chung D, Fleming BA, Lehmann MM, Puttikamonkul S, Cramer RA. 2012. Dsc orthologs are required for hypoxia
adaptation, triazole drug responses, and fungal virulence in Aspergillus
fumigatus. Eukaryot Cell 11:1557–1567. http://dx.doi.org/10.1128/
EC.00252-12.
35. Willger SD, Grahl N, Cramer RA, Jr. 2009. Aspergillus fumigatus
metabolism: clues to mechanisms of in vivo fungal growth and virulence.
Med Mycol 47(Suppl 1):S72–S79. http://dx.doi.org/10.1080/
13693780802455313.
36. Meyer RD, Young LS, Armstrong D, Yu B. 1973. Aspergillosis complicating neoplastic disease. Am J Med 54:6 –15. http://dx.doi.org/10.1016/
0002-9343(73)90077-64345262.
37. Fisher BD, Armstrong D, Yu B, Gold JW. 1981. Invasive aspergillosis.
Progress in early diagnosis and treatment. Am J Med 71:571–577. http://
dx.doi.org/10.1016/0002-9343(81)90208-4.
38. Kowalski CJ. 1972. On the effects of non-normality on the distribution of
the sample product-moment correlation coefficient. Appl Stat 21:1–12.
http://dx.doi.org/10.2307/2346598.
39. Shepardson KM, Ngo LY, Aimanianda V, Latgé JP, Barker BM,
Blosser SJ, Iwakura Y, Hohl TM, Cramer RA. 2013. Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell
wall modulation. Microbes Infect 15:259 –269. http://dx.doi.org/
10.1016/j.micinf.2012.11.010.
40. Sosinska GJ, de Groot PW, Teixeira de Mattos MJ, Dekker HL, de
Koster CG, Hellingwerf KJ, Klis FM. 2008. Hypoxic conditions and iron
restriction affect the cell-wall proteome of Candida albicans grown under
vagina-simulative conditions. Microbiology 154:510 –520. http://
dx.doi.org/10.1099/mic.0.2007/012617-0.
41. Neuvéglise C, Sarfati J, Debeaupuis JP, Vu Thien H, Just J, Tournier G,
Latgé JP. 1997. Longitudinal study of Aspergillus fumigatus strains isolated
from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 16:747–750.
http://dx.doi.org/10.1007/BF01709257.
42. Paisley D, Robson GD, Denning DW. 2005. Correlation between in vitro
growth rate and in vivo virulence in Aspergillus fumigatus. Med Mycol
43:397– 401. http://dx.doi.org/10.1080/13693780400005866.
43. Reeves EP, Messina CG, Doyle S, Kavanagh K. 2004. Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia 158:73–79. http://dx.doi.org/10.1023/
B:MYCO.0000038434.55764.16.
44. Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM,

September/October 2016 Volume 7 Issue 5 e01515-16

Hypoxia Fitness Correlates with A. fumigatus Virulence

45.

46.

47.
48.
49.

50.

51.

52.

53.

54.

55.

56.
57.

58.

Watschke CP, Hilmer KM, Thammahong A, Barker BM, Rivera A,
Cramer RA, Obar JJ. 2015. IL-1alpha signaling is critical for leukocyte
recruitment after pulmonary Aspergillus fumigatus challenge. PLoS Pathog
11:e1004625. http://dx.doi.org/10.1371/journal.ppat.1004625.
Karki R, Man SM, Malireddi RK, Gurung P, Vogel P, Lamkanfi M,
Kanneganti TD. 2015. Concerted activation of the AIM2 and NLRP3
inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe 17:357–368. http://dx.doi.org/10.1016/
j.chom.2015.01.006.
Janbon G, Ormerod KL, Paulet D, Byrnes EJ, III, Yadav V, Chatterjee
G, Mullapudi N, Hon CC, Billmyre RB, Brunel F, Bahn YS, Chen W,
Chen Y, Chow EW, Coppée JY, Floyd-Averette A, Gaillardin C, Gerik
KJ, Goldberg J, Gonzalez-Hilarion S, Gujja S, Hamlin JL, Hsueh YP,
Ianiri G, Jones S, Kodira CD, Kozubowski L, Lam W, Marra M, Mesner
LD, Mieczkowski PA, Moyrand F, Nielsen K, Proux C, Rossignol T,
Schein JE, Sun S, Wollschlaeger C, Wood IA, Zeng Q, Neuveglise C,
Newlon CS, Perfect JR, Lodge JK, Idnurm A, Stajich JE, Kronstad JW,
Sanyal K, Heitman J, Fraser JA, Cuomo CA, Dietrich FS. 2014. Analysis
of the genome and transcriptome of Cryptococcus neoformans var. grubii
reveals complex RNA expression and microevolution leading to virulence
attenuation. PLoS Genet 10:e1004261. http://dx.doi.org/10.1371/
journal.pgen.1004261.
Brummer E, Restrepo A, Hanson LH, Stevens DA. 1990. Virulence of
Paracoccidioides brasiliensis: the influence of in vitro passage and storage.
Mycopathologia 109:13–17. http://dx.doi.org/10.1007/BF00437001.
San-Blas G, San-Blas F. 1982. Variability of cell wall composition in
Paracoccidioides brasiliensis: a study of two strains. Sabouraudia 20:
31– 40. http://dx.doi.org/10.1080/00362178285380061.
Mallick EM, Bergeron AC, Jones SK, Jr, Newman ZR, Brothers KM,
Creton R, Wheeler RT, Bennett RJ. 2016. Phenotypic plasticity regulates
Candida albicans interactions and virulence in the vertebrate host. Front
Microbiol 7:780. http://dx.doi.org/10.3389/fmicb.2016.00780.
Sepúlveda VE, Williams CL, Goldman WE. 2014. Comparison of phylogenetically distinct Histoplasma strains reveals evolutionarily divergent
virulence strategies. mBio 5:e01376-14. http://dx.doi.org/10.1128/
mBio.01376-14.
Fedorova ND, Khaldi N, Joardar VS, Maiti R, Amedeo P, Anderson MJ,
Crabtree J, Silva JC, Badger JH, Albarraq A, Angiuoli S, Bussey H,
Bowyer P, Cotty PJ, Dyer PS, Egan A, Galens K, Fraser-Liggett CM,
Haas BJ, Inman JM, Kent R, Lemieux S, Malavazi I, Orvis J, Roemer T,
Ronning CM, Sundaram JP, Sutton G, Turner G, Venter JC, White OR,
Whitty BR, Youngman P, Wolfe KH, Goldman GH, Wortman JR, Jiang
B, Denning DW, Nierman WC. 2008. Genomic islands in the pathogenic
filamentous fungus Aspergillus fumigatus. PLoS Genet 4:e1000046. http://
dx.doi.org/10.1371/journal.pgen.1000046.
DuBois JC, Pasula R, Dade JE, Smulian AG. 2016. Yeast transcriptome
and in vivo hypoxia detection reveals Histoplasma capsulatum response to
low oxygen tension. Med Mycol 54:40 –58. http://dx.doi.org/10.1093/
mmy/myv073.
Heng Y, Seah PG, Siew JY, Tay HC, Singhal A, Mathys V, Kiass M,
Bifani P, Dartois V, Hervé M. 2011. Mycobacterium tuberculosis infection induces hypoxic lung lesions in the rat. Tuberculosis (Edinb) 91:
339 –341. http://dx.doi.org/10.1016/j.tube.2011.05.003.
Aly S, Wagner K, Keller C, Malm S, Malzan A, Brandau S, Bange FC,
Ehlers S. 2006. Oxygen status of lung granulomas in Mycobacterium
tuberculosis-infected mice. J Pathol 210:298 –305. http://dx.doi.org/
10.1002/path.2055.
Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein
E, Manjunatha U, Gonzales J, Lee EG, Park SK, Raleigh JA, Cho SN,
McMurray DN, Flynn JL, Barry CE, III. 2008. Tuberculous granulomas
are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76:2333–2340. http://dx.doi.org/10.1128/IAI.01515-07.
Rustad TR, Harrell MI, Liao R, Sherman DR. 2008. The enduring
hypoxic response of Mycobacterium tuberculosis. PLoS One 3:e1502.
http://dx.doi.org/10.1371/journal.pone.0001502.
Chang YC, Bien CM, Lee H, Espenshade PJ, Kwon-Chung KJ. 2007.
Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for
virulence in Cryptococcus neoformans. Mol Microbiol 64:614 – 629.
http://dx.doi.org/10.1111/j.1365-2958.2007.05676.x.
Brunke S, Seider K, Fischer D, Jacobsen ID, Kasper L, Jablonowski N,
Wartenberg A, Bader O, Enache-Angoulvant A, Schaller M, d’Enfert C,
Hube B. 2014. One small step for a yeast—microevolution within macro-

September/October 2016 Volume 7 Issue 5 e01515-16

59.

60.

61.

62.

63.

64.

65.
66.

67.

68.
69.

70.

71.
72.
73.
74.

75.

phages renders Candida glabrata hypervirulent due to a single point mutation. PLoS Pathog 10:. http://dx.doi.org/10.1371/journal.ppat.1004478
Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, Casadevall
A. 1998. Microevolution of a standard strain of Cryptococcus neoformans
resulting in differences in virulence and other phenotypes. Infect Immun
66:89 –97.
Wartenberg A, Linde J, Martin R, Schreiner M, Horn F, Jacobsen ID,
Jenull S, Wolf T, Kuchler K, Guthke R, Kurzai O, Forche A, d’Enfert C,
Brunke S, Hube B. 2014. Microevolution of Candida albicans in macrophages restores filamentation in a nonfilamentous mutant. PLoS Genet
10:e1004824. http://dx.doi.org/10.1371/journal.pgen.1004824.
Grahl N, Dinamarco TM, Willger SD, Goldman GH, Cramer RA. 2012.
Aspergillus fumigatus mitochondrial electron transport chain mediates oxidative stress homeostasis, hypoxia responses and fungal pathogenesis.
Mol Microbiol 84:383–399. http://dx.doi.org/10.1111/j.1365
-2958.2012.08034.x.
Barker BM, Kroll K, Vödisch M, Mazurie A, Kniemeyer O, Cramer RA.
2012. Transcriptomic and proteomic analyses of the Aspergillus fumigatus
hypoxia response using an oxygen-controlled fermenter. BMC Genomics
13:62. http://dx.doi.org/10.1186/1471-2164-13-62.
Vödisch M, Scherlach K, Winkler R, Hertweck C, Braun HP, Roth M,
Haas H, Werner ER, Brakhage AA, Kniemeyer O. 2011. Analysis of the
Aspergillus fumigatus proteome reveals metabolic changes and the activation of the pseurotin A biosynthesis gene cluster in response to hypoxia. J
Proteome Res 10:2508 –2524. http://dx.doi.org/10.1021/pr1012812.
Blatzer M, Barker BM, Willger SD, Beckmann N, Blosser SJ, Cornish
EJ, Mazurie A, Grahl N, Haas H, Cramer RA. 2011. SREBP coordinates
iron and ergosterol homeostasis to mediate triazole drug and hypoxia
responses in the human fungal pathogen Aspergillus fumigatus. PLoS
Genet 7:e1002374. http://dx.doi.org/10.1371/journal.pgen.1002374.
Hall LA, Denning DW. 1994. Oxygen requirements of Aspergillus species. J Med Microbiol 41:311–315. http://dx.doi.org/10.1099/00222615
-41-5-311.
Guzy RD, Mack MM, Schumacker PT. 2007. Mitochondrial complex III
is required for hypoxia-induced ROS production and gene transcription
in yeast. Antioxid Redox Signal 9:1317–1328. http://dx.doi.org/10.1089/
ars.2007.1708.
Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS. 2004.
Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci U S A 101:
10440 –10445. http://dx.doi.org/10.1073/pnas.0401339101.
Walmsley SR, Cadwallader KA, Chilvers ER. 2005. The role of HIF1alpha in myeloid cell inflammation. Trends Immunol 26:434 – 439.
http://dx.doi.org/10.1016/j.it.2005.06.007.
Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo
RL, Hurtado-Ziola N, Nizet V, Johnson RS. 2005. HIF-1alpha expression
regulates the bactericidal capacity of phagocytes. J Clin Invest 115:
1806 –1815. http://dx.doi.org/10.1172/JCI23865.
Shepardson KM, Jhingran A, Caffrey A, Obar JJ, Suratt BT, Berwin BL,
Hohl TM, Cramer RA. 2014. Myeloid derived hypoxia inducible factor
1-alpha is required for protection against pulmonary Aspergillus fumigatus
infection. PLoS Pathog 10:e1004378. http://dx.doi.org/10.1371/
journal.ppat.1004378.
Tekaia F, Latgé JP. 2005. Aspergillus fumigatus: saprophyte or pathogen? Curr Opin Microbiol 8:385–392. http://dx.doi.org/10.1016/
j.mib.2005.06.017.
Shimizu K, Keller NP. 2001. Genetic involvement of a cAMP-dependent
protein kinase in a G protein signaling pathway regulating morphological
and chemical transitions in Aspergillus nidulans. Genetics 157:591– 600.
National Research Council. 1996. Guide for the care and use of laboratory
animals. National Academies Press, Washington, DC.
Feng X, Krishnan K, Richie DL, Aimanianda V, Hartl L, Grahl N,
Powers-Fletcher MV, Zhang M, Fuller KK, Nierman WC, Lu LJ,
Latgé JP, Woollett L, Newman SL, Cramer RA, Jr., Rhodes JC, Askew
DS. 2011. HacA-independent functions of the ER stress sensor IreA
synergize with the canonical UPR to influence virulence traits in Aspergillus fumigatus. PLoS Pathog 7:e1002330. http://dx.doi.org/10.1371/
journal.ppat.1002330.
Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary
A, Meis JF, Armstrong-James D, Fisher MC. 2015. Genomic context of
azole resistance mutations in Aspergillus fumigatus determined by using
whole-genome sequencing. mBio 6:e00536-15. http://dx.doi.org/10.1128/
mBio.00536-15.

®

mbio.asm.org 13

